Pulmatrix, Inc. Common Stock
Symbol: PULM (NASDAQ)
0.00
▼ (-100.00%) -4.870
Company Description:
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $4.87
- Yesterday High: $4.91
- Yesterday Low: $4.8
- Yesterday Volume: 5.01K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Pulmatrix, Inc. Common Stock
- Website: https://www.pulmatrix.com
- Listed Date: 2014-03-21
- Location: FRAMINGHAM, MA
- Market Status: Active
- CIK Number: 0001574235
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $17.79M
- Round Lot: 100
- Outstanding Shares: 3.65M
- Asset Type: CS
RECENT FILINGS FOR PULM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-06-16 | 425 | View |
| 2025-06-16 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
| 2025-05-09 | EFFECT | View |
| 2025-05-09 | 424B3 | View |
| 2025-05-08 | CORRESP | View |
| 2025-05-07 | CORRESP | View |
| 2025-05-07 | S-4/A | View |
| 2025-04-17 | S-4/A | View |
| 2025-04-17 | CORRESP | View |
| 2025-04-10 | 8-K | View |
| 2025-04-08 | 8-K | View |
| 2025-03-21 | 10-K | View |
| 2025-03-21 | 8-K | View |
| 2025-03-17 | UPLOAD | View |
| 2025-02-14 | S-4 | View |
| 2025-02-14 | 8-K | View |
Latest News on PULM